Targeting lipid metabolism overcomes BTK inhibitor resistance in diffuse large B-cell lymphoma
Author:
Funder
Academic Excellence Foundation of BUAA for PHD Students
Publisher
Elsevier BV
Reference59 articles.
1. Burden of lymphoma in China, 2006-2016: an analysis of the global burden of disease study 2016;Liu;J Hematol Oncol,2019
2. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the groupe d'etudes des lymphomes de l'adulte;Coiffier;Blood,2010
3. Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study;Van Den Neste;Bone Marrow Transplant,2017
4. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy;Jurinovic;Blood,2016
5. Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors;Telio;Leuk Lymphoma,2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3